64 foreign envoys, who are scheduled to visit leading biotech companies - Bharat Biotech and Biological E - which are developing vaccines against the novel coronavirus, have left for Hyderabad
64 foreign envoys, who are scheduled to visit leading biotech companies - Bharat Biotech and Biological E - which are developing vaccines against the novel coronavirus, have left for Hyderabad.
Sources said that this is
the first such visit and it will be followed by visits to facilities in other
cities.
It is in continuation of
the COVID-19 briefing by the Ministry of External Affairs on November 6.
India is the world's
largest vaccine manufacturer and has been contributing significantly to global
efforts against COVID-19
pandemic.
Sources said there is a lot
of interest in India's vaccine development efforts.
Prime Minister Narendra
Modi has said that India's vaccine production and delivery capacity will be
used to help all humanity in fighting this crisis.
He visited the Zydus
Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of
India in Pune on November 28 to conduct an extensive review of the vaccine
development and manufacturing process.
On November 30, he had
virtual meetings with teams from Gennova Biopharmaceuticals Ltd Pune, Biological
E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad. The three teams are
working on developing and manufacturing vaccine for COVID-19.
Bharat
Biotech had on Monday applied for emergency use authorisation for its
indigenously developed COVID-19 vaccine 'Covaxin' to Drugs Controller General
of India (DCGI).
It is the second Indian
company to apply for emergency use authorisation after the Serum Institute of
India applied for such use for the vaccine developed by Oxford University and
AstraZeneca.
No comments:
Post a Comment